R
70
3
MSI
40
5
MSFT
43
-4
VNO
49
4
EQR
36
5
IFF
53
3
SRE
56
2
CNP
55
3
CVS
52
3
MKC
36
6
EXR
33
3
GM
80
6
SLB
60
3
EXC
56
2
KHC
36
2
LMT
67
5
CL
40
9
AA
72
-2
PNR
60
4
CTAS
39
5
R
70
3
MSI
40
5
MSFT
43
-4
VNO
49
4
EQR
36
5
IFF
53
3
SRE
56
2
CNP
55
3
CVS
52
3
MKC
36
6
EXR
33
3
GM
80
6
SLB
60
3
EXC
56
2
KHC
36
2
LMT
67
5
CL
40
9
AA
72
-2
PNR
60
4
CTAS
39
5
Financhill
Back

Invesco Biotechnology & Genome ETF Stock Predictions

Meet America's Newest $1B Unicorn

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
67

PBE
Invesco Biotechnology & Genome ETF

Last Price:
$84.39
Seasonality Move:
1.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Exxon and Chevron Have an Unlikely New Competitor

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

Invesco Biotechnology & Genome ETF Stock Forecast

  • Over the next 52 weeks, Invesco Biotechnology & Genome ETF has on average historically risen by 10% based on the past 20 years of stock performance.
  • Invesco Biotechnology & Genome ETF has risen higher in 15 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Invesco Biotechnology & Genome ETF Stock Undervalued?
    The current Invesco Biotechnology & Genome ETF [PBE] share price is $84.22. The Score for PBE is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • PBE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Invesco Biotechnology & Genome ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Invesco Biotechnology & Genome ETF has on average historically risen by 10% based on the past 20 years of stock performance.

Invesco Biotechnology & Genome ETF Stock Rating

Buy
67
Invesco Biotechnology & Genome ETF (PBE) is a Buy

Is Invesco Biotechnology & Genome ETF overpriced?

  • Invesco Biotechnology & Genome ETF has risen higher in 15 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Invesco Biotechnology & Genome ETF Stock Price History

Is PBE stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PBE is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
85.73
52-Week Low:
54.52

Prediction Charts

Market Cap:
0
Price in USD:
84.22
Volume:
5.6K
Beta:
0.93

Technical Analysis

SMA50:
79.62
SMA100:
74.90
SMA200:
69.12
52-Wk Change:
22.2%

Stock Predictions

  • Is Invesco Biotechnology & Genome ETF stock public?
    Yes, Invesco Biotechnology & Genome ETF is a publicly traded company.
  • What is the Invesco Biotechnology & Genome ETF stock quote today?
    The Invesco Biotechnology & Genome ETF stock price is 84.22 USD today.
  • How to buy Invesco Biotechnology & Genome ETF stock online?
    You can buy Invesco Biotechnology & Genome ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-16 80.97 80.30 80.97 79.92
Dec-17 80.50 80.15 80.87 80.15
Dec-18 80.06 79.94 80.38 79.80
Dec-19 80.97 82.71 83.00 80.97
Dec-22 82.30 83.21 83.38 82.30
Dec-24 83.92 84.16 84.17 83.92
Dec-26 84.12 83.82 84.18 83.50
Dec-29 83.84 83.44 83.84 83.29
Dec-30 83.16 82.41 83.23 82.31
Dec-31 82.25 82.15 82.57 82.06
Jan-5 82.15 82.40 82.49 81.33
Jan-6 83.32 84.06 84.06 82.93
Jan-7 84.43 85.73 85.73 84.43
Jan-8 84.97 84.22 85.21 83.85

Invesco Biotechnology & Genome ETF Earnings

Data Unavailable

Invesco Biotechnology & Genome ETF Forecast Revenue Growth

Data Unavailable

* Invesco Biotechnology & Genome ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.